Liu Xiang 4
4 · BlackRock Health Sciences Trust · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Liu Xiang
Other
Transactions
- Exercise/Conversion
Phantom Shares
2025-01-31−91.972→ 91.972 total→ Common Stock (91.972 underlying) - Disposition to Issuer
Common Stock
2025-01-31$40.92/sh−281.023$11,499→ 0 total - Exercise/Conversion
Phantom Shares
2025-01-31−109.367→ 0 total→ Common Stock (109.367 underlying) - Exercise/Conversion
Common Stock
2025-01-31+281.023→ 281.023 total - Award
Phantom Shares
2025-01-31$40.92/sh+559.433$22,892→ 559.433 total→ Common Stock (559.433 underlying) - Exercise/Conversion
Phantom Shares
2025-01-31−79.684→ 159.368 total→ Common Stock (79.684 underlying)
Footnotes (5)
- [F1]A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.
- [F2]As previously reported on a Form 4 dated February 2, 2024, the Reporting Person was granted phantom shares on January 31, 2024 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F3]As previously reported on a Form 4 dated February 2, 2023, the Reporting Person was granted phantom shares on January 31, 2023 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F4]As previously reported on a Form 4 dated February 2, 2022, the Reporting Person was granted phantom shares on January 31, 2022 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.
- [F5]These phantom shares vest in equal installments on each of the first three anniversaries of the award.